by ASTCT Science Highlights
Allogeneic hematopoietic cell transplantation (HCT) did not yield any benefits for older and medically infirm patients with acute myeloid leukemia (AML), according to a new research. For the...
by ASTCT Science Highlights
A combination of technologies paved the way for DNA transposon-based production of primary, donor-derived chimeric antigen receptor (CAR)-natural killer (NK) cells, which subsequently demonstrated...
by ASTCT Science Highlights
A follow-up analysis of the prospective ALL-SCT-BFM-2003 trial and its subsequent extension registry confirmed a higher risk of subsequent malignant neoplasms (SMN) in children with acute...
by ASTCT Science Highlights
Chimeric antigen receptor T cells (CART) specific to the TCRvß family recognize and kill target cells that express TCRvß, including malignant clones, while minimizing depletion of healthy,...
by ASTCT Science Highlights
A study of the late effects of mantle cell lymphoma (MCL) found that most patients died from the disease, rather than as the result of another cause or treatment complication — highlighting...
by ASTCT Science Highlights
Researchers believe suppression of transforming growth factor ß1 (TGF-ß1) signaling might be one way to improve outcomes in patients with acute myeloid leukemia (AML) who relapse soon after...